Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Sunrest Lifescience Ltd

NSE: SUNREST · Pharmaceuticals & Biotechnology · 26 announcements

Share price
₹38.50
Market cap
₹33.04 Cr
Revenue (annual)
₹70.83 Cr
Net profit (annual)
₹4.12 Cr
P/E (TTM)
8.0×Sector 47.4×
Promoter holding
53.50%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

16:54 IST NSE
Board Meeting Date

Sunrest Lifescience Board Meeting Date

Sunrest Lifescience Limited has scheduled a board meeting for August 12, 2026. The meeting will address general business matters.

13:18 IST NSE
Board Meeting Date

Sunrest Lifescience Board Meeting Date

Sunrest Lifescience rescheduled its board meeting to July 30, 2026. The meeting's agenda includes a fund raise via rights issue.

11:01 IST NSE
Board Meeting Date

Sunrest Lifescience Board Meeting Date

Sunrest Lifescience rescheduled its board meeting to July 17, 2026. The meeting will consider a proposed rights issue for fund raising.

17:48 IST NSE
Board Meeting Date

Sunrest Lifescience Board Meeting Date

Sunrest Lifescience rescheduled its board meeting to July 10, 2026. The agenda includes a proposed fund raise via a rights issue.

16:48 IST NSE
Board Meeting Date

Sunrest Lifescience Board Meeting Date

Sunrest Lifescience Limited scheduled a board meeting on May 29, 2026, to approve audited annual financial results. The company's trading window remains closed until June 2026.